Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. They focus almost exclusively on oncology therapeutics, and on helping to drive value creation for their portfolio companies. They invest in the most promising drug discovery companies with the potential to create multiple medicines. Their portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds.

Venture Capital

Nextech Invest

Alfred Scheidegger

Alessia Jaeggli

Akasha Abraham

Stella Paffenholz

Jules Ketterlin

Johanna Dürmüller - Bol

Joanna Triscott

Alexis Borisy

Melissa McCracken

Marco Weibel

Kanishka Pothula

Rich Heyman

The leadership team at Nextech Invest have a wealth of experience in the biotech industry, with board memberships at companies such as Hexagon Bio, Flare Therapeutics, Boundless Bio, and IconOVir Bio. They also boast impressive educational backgrounds, with degrees from renowned institutions such as the Karolinska Institutet and Anglia Ruskin University.

Leadership Team

Leadership Team

About

Team members